FdaApplication
NDA 215014
Identifiers
- fda_app_no: NDA215014
Properties
| Property | Value |
|---|---|
| applicant_name | APELLIS PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2021-05-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAVELI | PEGCETACOPLAN | 1080MG/20ML (54MG/ML) | SOLUTION;SUBCUTANEOUS |
1 product